Monod Bio Closes $25M Seed Financing to Advance Biosensor Technology Platform
Summary
Monod Bio, a life sciences company developing custom diagnostic biosensors that emit light to detect specific biomolecules of interest, today announced it has raised a $25M seed financing round. The company plans to double the size of its research and engineering teams in the coming 18 months.Monod was founded in November 2021 from technology developed at David Bakers lab at the University of Washington Institute for Protein Design. Monod Bios work illustrates the power of de novo protein design to create molecular devices from scratch with new and useful functions, said David Baker, Ph.D., the Henrietta and Aubrey Davis Endowed Professor of Biochemistry at the University of Washington School of Medicine, a Howard Hughes Medical Institute investigator, Co-founder of Monod Bio, and the Founder and Director of IPD.LucCage is a paradigm-shifting platform for biosensors development, and were excited to have the support of top-tier investors to advance our team and technology, said Alfredo Quijano Rubio, Ph.D, Chief Scientific Officer, Co-Founder and the main inventor of Monods LucCagetechnology.Monod is using synthetic biology to draw on the architecture of living organisms to attain high detection sensitivity and accuracy at scale, due to low costs with biosensors compared to conventional laboratory-testing, said Karan Takhar, Managing Partner, Matrix Capital. Our partnership with Monod Bio reflects our commitment to back extraordinary teams unlocking breakthrough innovation at the intersection of technology and life sciences.Monod is taking recent advances in computational protein engineering, and leading the field in creating highly modular biosensors to develop rapid, sensitive, and cost-effective analytical assays, said Damien Soghoian, Partner, Global Health Investment Corporation. Monod Bios innovative biosensor platform technology uses computational protein engineering to create highly modular biosensing nanoswitches that enable rapid, sensitive, and cost-effective analytical assays.